New evidence-based guidelines from the American College of Chest Physicians (ACCP) recommend considering individual patients' risk of thrombosis when deciding for or against the use of preventive ...

Please provide your email address to receive an email when new articles are posted on . Until recently, orthopedic surgeons lacked specialty-specific recommendations for preventing venous ...

Am J Health Syst Pharm. 2006;63(24):2448-2450. Q: It has become very common to use expensive low-molecular-weight heparins (LMWHs) for prophylaxis of deep venous thrombosis (DVT) in hospitalized ...

DVT prophylaxis reduces the risk of developing deep vein thrombosis through medications, compression stockings, and devices. Deep vein thrombosis (DVT) can occur when a blood clot forms in a deep vein ...

For patients presenting with symptoms of venous thromboembolism, accurate diagnosis and treatment are essential. However, diagnosis and treatment alone are inadequate for hospitalized patients who are ...

There is broad consensus regarding the importance of thromboprophylaxis in hospitalized patients with cancer, including prolonged prophylaxis in high-risk surgical patients. Prophylaxis is not ...

ASH and ISTH sought to develop clinical practice guidelines on anticoagulant prophylaxis for pediatric patients who are at risk of VTE.

“Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines” offers more than 600 recommendations for the diagnosis, ...

Twelve recommendations issued, including suggestion for no anticoagulants for pediatric patients with solid cancer, trauma, critical illness.

(WASHINGTON, Apr. 8, 2026) — The American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) released comprehensive clinical practice guidelines on ...

The majority of fatal cases of pulmonary embolism in hospitalized patients occur in acutely ill, medically treated patients. Current guidelines, based on a large number of prospective, randomized, ...

Provider Recommendations for Phase I Clinical Trials Within a Shared Decision-Making Model in Phase I Cancer Clinical Trial Discussions Venous Thromboembolism Prevention in the Ambulatory Cancer ...